Showing results (691-700 of 715) with videos related to
Sort By:
Pageof 72
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.Nature|July 23, 2016
Replication fork stability confers chemoresistance in BRCA-deficient cellsArnab Ray Chaudhuri, Elsa Callen, Xia Ding, et al.Gut|February 14, 2018
Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levelsFernando Magro, Joanne Lopes, Paula Borralho, et al.Ecology|October 25, 2024
Leaf architecture and functional traits for 122 species at the University of California Botanical Garden at BerkeleyIlaine Silveira Matos, Mickey Boakye, Monica Antonio, et al.Genomics|October 28, 2022
Phylogenomics and gene selection in Aspergillus welwitschiae: Possible implications in the pathogenicity in Agave sisalanaGabriel Quintanilha-Peixoto, Marina Püpke Marone, Fábio Trigo Raya, et al.Journal of Crohn'S & Colitis|September 25, 2016
Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE studyFernando Magro, Susana Lopes, Rosa Coelho, et al.Journal of Crohn'S & Colitis|September 11, 2019
Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin LevelsFernando Magro, Joanne Lopes, Paula Borralho, et al.Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.Multiple Sclerosis and Related Disorders|February 15, 2025
Central American and Caribbean consensus for the treatment of MS, NMOSD, and MOGADDeyanira A Ramirez, Fernando Gracia, Alejandro J Diaz Jimenez, et al.Pageof 72